Table 5 Study assessments and specimen collection

 WHO Standard of Care^a,b

X

X

X

X

(X)

X

 TB clinical assessment^c

(X)

(X)

(X)

(X)

(X)

 TB treatment if needed^{b, d}

(X)

(X)

(X)

(X)

(X)

 Nasopharyngeal aspirate

X

 Stool sample

X

 Xpert MTB/RIF Ultra

X

 Immediate TB treatment initiation if positive Ultra test^b

X

 Biobank: NPA and stool leftovers

X

 Tolerability and acceptability of NPA collection^h

X

 Eligibility screening

X

 Clinical evaluation^e

X

X

X

X

(X)

X

 Medical history

X

X

X

X

(X)

X

 Digital chest X-Ray

X

(X)

X

 Safety assessment

X

X

X

X

(X)

X

 TB drug adherence assessment

(X)

(X)

(X)

(X)

 TB treatment response

X

X

 HIV test^f

X

 Malaria test

X

 Complete blood count

X

 Biobank: plasma, whole blood^g

X